Low chronic inflammation in the myocardium is one of the main causes of diabetic cardiomyopathy [44,45]; hence, the inhibition of NLRP3 inflammasome-mediated inflammation can effectively improve diabetic cardiomyopathy [46,47]. This evidence concerns the gene NLRP3 and diabetic cardiomyopathy.